Molecular basis of Pirh2-mediated p53 ubiquitylation

被引:87
|
作者
Sheng, Yi [1 ,2 ,4 ]
Laister, Rob C. [1 ,2 ]
Lemak, Alexander [1 ,2 ]
Wu, Bin [1 ,2 ]
Tai, Elizabeth [1 ,2 ]
Duan, Shili [1 ,2 ]
Lukin, Jonathan [1 ,2 ]
Sunnerhagen, Maria [3 ]
Srisailam, Sampath [1 ,2 ]
Karra, Murthy [1 ,2 ]
Benchimol, Sam [4 ]
Arrowsmith, Cheryl H. [1 ,2 ]
机构
[1] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada
[3] Linkoping Univ, IFM, S-58183 Linkoping, Sweden
[4] York Univ, Dept Biol, N York, ON M3J 1P3, Canada
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nsmb.1521
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pirh2 (p53-induced RING-H2 domain protein; also known as Rchy1) is an E3 ubiquitin ligase involved in a negative-feedback loop with p53. Using NMR spectroscopy, we show that Pirh2 is a unique cysteine-rich protein comprising three modular domains. The protein binds nine zinc ions using a variety of zinc coordination schemes, including a RING domain and a left-handed beta-spiral in which three zinc ions align three consecutive small beta-sheets in an interleaved fashion. We show that Pirh2-p53 interaction is dependent on the C-terminal zinc binding module of Pirh2, which binds to the tetramerization domain of p53. As a result, Pirh2 preferentially ubiquitylates the tetrameric form of p53 in vitro and in vivo, suggesting that Pirh2 regulates protein turnover of the transcriptionally active form of p53.
引用
收藏
页码:1334 / 1342
页数:9
相关论文
共 50 条
  • [41] P53 α-helix mimetics antagonize p53/MDM2 interaction and activate p53
    Chen, LH
    Yin, H
    Farooqi, B
    Sebti, S
    Hamilton, AD
    Chen, JD
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) : 1019 - 1025
  • [42] Molecular basis for the accelerated senescence response to doxorubicin in p53 wild-type and p53 null/mutant breast tumor cells.
    Di, Xu
    Gewirtz, David
    CANCER RESEARCH, 2009, 69
  • [43] Reciprocal down-regulation of p53 and SOD2 gene expression–implication in p53 mediated apoptosis
    Pascal Drane
    Anne Bravard
    Véronique Bouvard
    Evelyne May
    Oncogene, 2001, 20 : 430 - 439
  • [44] Reciprocal down-regulation of p53 and SOD2 gene expression -: implication in p53 mediated apoptosis
    Drane, P
    Bravard, A
    Bouvard, V
    May, E
    ONCOGENE, 2001, 20 (04) : 430 - 439
  • [45] PRPF8 controls alternative splicing of PIRH2 to modulate the p53 pathway and survival of human ESCs
    Sun, Yiyang
    Zhang, Lingling
    Fang, Zhuoqing
    Liu, Dingyu
    Shao, Min
    Liu, Yujie
    Liao, Bing
    Jin, Ying
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (08) : 1909 - 1920
  • [46] Human securin: a p53 mediated protooncogene
    Wu, Chang You
    Chao, Jui-I
    Chu, Hsueh-Liang
    Chang, Pei-Hsin
    Lo, Chiu-An
    Chao, Hsiu-Ming
    Chang, Chia-Ching
    FASEB JOURNAL, 2007, 21 (05): : A634 - A634
  • [47] DNA-Mediated Oxidation of p53
    Schaefer, Kathryn N.
    Barton, Jacqueline K.
    BIOCHEMISTRY, 2014, 53 (21) : 3467 - 3475
  • [48] Structural basis of DNA recognition by p53 tetramers
    Kitayner, Malka
    Rozenberg, Haim
    Kessler, Naama
    Rabinovich, Dov
    Shaulov, Lih
    Haran, Tali E.
    Shakked, Zippora
    MOLECULAR CELL, 2006, 22 (06) : 741 - 753
  • [49] Zinc deficiency causes neural tube defects through attenuation of p53 ubiquitylation
    Li, Huili
    Zhang, Jing
    Niswander, Lee
    DEVELOPMENT, 2018, 145 (24):
  • [50] Nanoparticle mediated inhibition of the MDM2:p53 interaction
    Arvizo, Rochelle R.
    Fischer, Nicholas O.
    Jerry, D. Joseph
    Rotello, Vincent M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233